3D Cell Cultures: Novel Approaches and Opportunities Ahead

Published: June 2015

Roots Analysis has announced the addition of “3D Culture Market, 2015-2025” report to their offering. The 3D culture approach is emerging as a promising tool that surmounts the limitations posed by monolayer or 2D culture systems. The report provides an extensive study on several promising 3D culture systems being explored for various biomedical applications.

Ishita Nanda, the principal analyst, said, “Presently, there are several scaffold-based and scaffold-free 3D systems in the market that are widely being used for the purpose of research in a variety of application areas. Although 2D cultures are still more prominent, the encouraging results of 3D cultures have motivated researchers across the world to gradually transition to 3D cultures systems.”

Cancer research is currently the most well established application area and accounts for 40% of the present 3D culture market. Drug and toxicity screening have also emerged quite popular. Going forward, stem cells and regenerative medicine are likely to gradually gain focus as the market establishes in the field of therapeutics.

Nanda further stated, “The report covers various aspects, such as, key players in the industry, 3D culture products in various biomedical applications and upcoming opportunities for several stakeholders. As pharmaceutical companies continue to expand their research programs in this area, one of the key objectives outlined for this report is to understand the current and future potential of the market. This is done by analysing current trends in the wider cell culture market and the specific parameters which are likely to influence evolution of 3D cultures during the same time period.”

“In addition, we have provided our outlook on the sub-market evolution of 3D culture instruments, 3D culture related consumables, 3D culture services and other biomaterials. We have also reviewed, in detail, the likely contribution to be made by different applications areas such as cancer research, drug and toxicity screening, stem cell research and regenerative medicines. The report also provides a snapshot of the likely evolution of the market across key geographies (US, EU and Asia).”


Who will benefit from this report?

The research is targeted towards big and small pharma companies interested in getting a comprehensive view in the field of 3D cell culture market. In particular, you could benefit if you are an:

  • Investor
  • CXO level decision maker
  • R&D manager
  • Business Intelligence / Scientific analyst
  • Finance manager
  • Strategy head

For additional details and/or to request sample pages, please visit https://www.rootsanalysis.com/reports/3d-cell-culture-market-2015-2025/97.html Alternatively, you can email at sales@rootsanalysis.com for further details.


About Roots Analysis

Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like us to help you with your growing business needs, get in touch at info@rootsanalysis.com


  • We are your partners with no equity

  • We fit in your budget

  • We love what we do

  • Chance to prove ourselves

  • Best in class quality of work

  • Most trusted consulting partner in the industry